What is iQure Pharma worth?
$21.0Mlast known valuation
iQure Pharma last raised $650K in its Seed Round (May 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for iQure Pharma
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Seed Round | $650K | ▮ | ▮ |
| Sep 2025 | Seed Round | $1.5M | ▮ | ▮ |
| Dec 2024 | Debt | $1.4M | ▮ | ▮ |
| Oct 2023 | Seed Round | $1.5M | ▮ | ▮ |
How iQure Pharma's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For iQure Pharma, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is iQure Pharma worth?
- iQure Pharma's last known valuation is $21.0M.
- How much has iQure Pharma raised?
- iQure Pharma has raised $13.1M in total funding across 4 recorded rounds.
- When did iQure Pharma last raise?
- iQure Pharma last raised in May 2026 (Seed Round), raising $650K.